Growing revenues for marine ingredient company Aqua Bio Technology
Aqua Bio Technology ASA (Oslo Axess: ABT) recently announced its first quarter 2013 financial results. The Company continued its revenue build-up and posted an EBITDA of 3.9 million.
ABT’s revenues were NOK 7.2 million in the first quarter, against NOK 3.4 million in the previous quarter. In the first quarter of 2012 the Company had revenues of NOK 11.9 million, which included sign-on fees for major contracts.
The sales growth is reflected in the NOK 3.9 million EBITDA, which is up from an EBITDA of NOK 0.2 million the previous quarter. The first quarter of 2012 provided EBITDA of NOK 9.6 million.
Aqua Bio Technology ASA (ABT) develops, produces and markets patented ingredients and technologies to the international cosmetic and skin care industry. ABT’s ingredients Aquabeautine XL, Dermaclarine and Beauty Propelline are marine solutions derived from the hatching fluid of salmon, while Oceanx Oil in Serum is based on extract from seaweed.